Amikacin (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Amikacin" in Serbian language version.

refsWebsite

Global rank Serbian rank

3clinicaltrials.gov

5,225^th place

6,444^th place

1clinicaltrialsregister.eu

low place

low place

low place

low place

1web.archive.org

1^st place

1^st place

clinicaltrials.gov

Study to Evaluate Arikace™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections
"A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikace™) in Patients With Recalcitrant Nontuberculous Mycobacterial Lung Disease" is a Phase II clinical trial in collaboration with the US National Institute of Allergy and Infectious Diseases
"A Placebo Controlled, Randomized, Parallel Cohort, Safety And Tolerability Study Of 2 Dose Levels Of Liposomal Amikacin For Inhalation (Arikace™) In Patients With Bronchiectasis Complicated By Chronic Infection Due To Pseudomonas Aeruginosa" Phase II (completed).

clinicaltrialsregister.eu

"Randomized, open-label, active-controlled, multicenter study to assess the efficacy, safety and tolerability of Arikace™ in Cystic Fibrosis patients with chronic infection due to Pseudomonas aeruginosa" is a European Phase III clinical trial, being conducted across multiple sites in the EU, starting at the Royal Brompton Hospital, Department of Respiratory Medicine, in London

nihr.ac.uk

ukctg.nihr.ac.uk

"A Study to Determine the Safety and Tolerability of Arikace™ Versus Placebo in Patients Who Have Bronchiectasis" Архивирано на сајту Wayback Machine (29. април 2015) is a Phase II clinical trial (as [4]) completed in the UK.

web.archive.org

"A Study to Determine the Safety and Tolerability of Arikace™ Versus Placebo in Patients Who Have Bronchiectasis" Архивирано на сајту Wayback Machine (29. април 2015) is a Phase II clinical trial (as [4]) completed in the UK.